- Title:
- Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis
- Authors:
- Source:
- In JTO Clinical and Research Reports February 2024 5(2)
Academic Journal
Dear user, the application need JavaScript support. Please enable JavaScript in your browser.